Skip to main content
Donate

FAST presents at the MENA Congress for Rare Diseases Angelman Symposium

“Flying from the country of cedars, Lebanon, to UAE, Abu Dhabi this year, was for me a different journey. A trip that ended with tens of brothers and sisters to my angel Miya. I left my family at home to meet homes and families from all over the world emphasizing devotion, determination, resilience, courage and hope. United by amazing intention for better future for our angels, we attended high calibre scientific conferences and stories that shaked our hearts. The FAST presentation opened for me opportunities that will be passionately invested in order to keep the shine of our angels' smiles.” - Rabih Turkieh, parent of Miya, who lives with AS

FAST was honored to participate in the Angelman Symposium of the MENA (Middle East North Africa) Congress for Rare Diseases last week. Amelia Beatty (FAST HQ board secretary living in Amman, Jordan) presented the Angelman Syndrome Therapeutic Landscape & FAST's Roadmap to a Cure 2.0, while Sally Asfour (FAST Australia board treasurer who grew up in the Middle East) shared her experience of having a child who lives with AS.

Congratulations to Dr Ayman El-Hattab and his team, including Dr Fida Dyab (Angelman mom), for organizing this important conference for the region. As Dr Ayman said in his opening remarks of the congress, "people with rare diseases in the MENA region face significant challenges including limited knowledge about their diseases, a long diagnostic journey, inadequate clinical management and support, and poor access to clinical trials and novel therapies. This conference is a unique platform that brings all stakeholders involved in rare diseases to one place to obtain the most updated knowledge, exchange experience, advance research, establish networks, and explore collaborative opportunities aiming ultimately to provide better care for individuals with rare diseases."

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.